The Evolving Role of Immunotherapy in Late-Stage Sinonasal Melanoma

Objective To evaluate the emerging role of immunotherapy as primary modality of treatment or in combination with traditional therapies in late-stage sinonasal mucosal melanoma (SNMM). Immunotherapy has been successfully used to treat patients with mucosal and cutaneous melanoma. The expanding success of immunotherapy in these regions suggests a potential role in the treatment of sinonasal melanomas (SNMM).